Showing posts by Miganush Stepanians, PhD

Show all

  • PROMETRIKA is proud to have participated in the Texas relief effort by donating to the following Feeding America Food Banks: 

    • Central Texas Food Bank – Austin
    • Houston Food Bank – Houston
    • San Antonio Food Bank – San Antonio
    • El Pasoans Fighting Hunger – El Paso
  • Miganush Stepanians, PhD, President and CEO of PROMETRIKA is excited to be presenting a summary of her experiences in rare disease study design and analysis at the 17th Annual WORLDSymposium on Thursday, February 11, 2021 from 1:30 - 2:00 p.m ET.

    Her presentation is titled “A Survey of Statistical Study Design and Analysis Methods for Rare Disease Development Programs”.

  • PROMETRIKA is pleased to present the sixth issue of our biannual newsletter.  We want to keep you informed of our growth and the progress of our internal initiatives and technological and methodological innovations, which directly translate to more and better services for your clinical research programs. We hope you will enjoy reading about PROMETRIKA’s recent accomplishments and activities.

  • PROMETRIKA is pleased to present the fifth issue of our biannual newsletter.  We want to keep you informed of our growth and the progress of our internal initiatives and technological and methodological innovations, which directly translate to more and better services for your clinical research programs. We hope you will enjoy reading about PROMETRIKA’s recent accomplishments and activities.

  • A message from PROMETRIKA’s President and CEO

    The Global COVID-19 pandemic is having a profound impact on communities and individuals worldwide.  Our daily lives have changed drastically and the sequelae of this pandemic are likely to be long-lasting. PROMETRIKA continues to monitor the evolving picture of COVID-19 spread worldwide as well as the pharmaceutical and biotechnology companies’ and clinical research community’s extraordinary and tireless efforts to combat this disease by developing vaccines and novel treatments. In these unprecedented times, we remain focused and committed to our core values of excellence, flexibility, and above all caring for the well-being of our sponsors, patients, employees and their families.